Learning embedded Android N programming: create the perfectly customized system by unleashing the power of Android OS on your embedded device

por Morgillo, Ivan, Viola, Stefano
Publicado 2016

O018. The increased flow pulsatility into cerebral arterial network may play a role in the pathogenic mechanism of migraine headache?

por Viola, Stefano, Viola, Paolo, Buongarzone, Maria P, Cipulli, Mafalda, Fiorelli, Luisa, Litterio, Pasquale
Publicado 2015

Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study

por De Matteis, Eleonora, Caponnetto, Valeria, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Maddestra, Maurizio, Viola, Stefano, Pistoia, Francesca, Sacco, Simona, Ornello, Raffaele
Publicado 2022

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy

por Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona
Publicado 2020

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region

por Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Caponnetto, Valeria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona
Publicado 2020

Association between response to triptans and response to erenumab: real-life data

por Frattale, Ilaria, Caponnetto, Valeria, Casalena, Alfonsina, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Affaitati, Giannapia, Giamberardino, Maria Adele, Viola, Stefano, Gabriele, Amleto, Pistoia, Francesca, Cerone, Davide, Marini, Carmine, Sacco, Simona, Ornello, Raffaele
Publicado 2021

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men

por Ornello, Raffaele, Baraldi, Carlo, Guerzoni, Simona, Lambru, Giorgio, Fuccaro, Matteo, Raffaelli, Bianca, Gendolla, Astrid, Barbanti, Piero, Aurilia, Cinzia, Cevoli, Sabina, Favoni, Valentina, Vernieri, Fabrizio, Altamura, Claudia, Russo, Antonio, Silvestro, Marcello, Dalla Valle, Elisabetta, Mancioli, Andrea, Ranieri, Angelo, Alfieri, Gennaro, Latysheva, Nina, Filatova, Elena, Talbot, Jamie, Cheng, Shuli, Holle, Dagny, Scheffler, Armin, Nežádal, Tomáš, Čtrnáctá, Dana, Šípková, Jitka, Matoušová, Zuzana, Sette, Lucia, Casalena, Alfonsina, Maddestra, Maurizio, Viola, Stefano, Affaitati, Giannapia, Giamberardino, Maria Adele, Pistoia, Francesca, Reuter, Uwe, Sacco, Simona
Publicado 2021

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study

por Ornello, Raffaele, Baraldi, Carlo, Guerzoni, Simona, Lambru, Giorgio, Andreou, Anna P., Raffaelli, Bianca, Gendolla, Astrid, Barbanti, Piero, Aurilia, Cinzia, Egeo, Gabriella, Cevoli, Sabina, Favoni, Valentina, Vernieri, Fabrizio, Altamura, Claudia, Russo, Antonio, Silvestro, Marcello, Valle, Elisabetta Dalla, Mancioli, Andrea, Ranieri, Angelo, Alfieri, Gennaro, Latysheva, Nina, Filatova, Elena, Talbot, Jamie, Cheng, Shuli, Holle, Dagny, Scheffler, Armin, Nežádal, Tomáš, Čtrnáctá, Dana, Šípková, Jitka, Matoušová, Zuzana, Casalena, Alfonsina, Maddestra, Maurizio, Viola, Stefano, Affaitati, Giannapia, Giamberardino, Maria Adele, Pistoia, Francesca, Reuter, Uwe, Sacco, Simona
Publicado 2022